glp-1 obesity drugs news today 2025 As continue to gain popularity for weight loss, a lesser-known side effect is drawing attention from podiatrists: “Ozempic feet.” Story🔗below Periodic Graphics: The science of

Idris, I., Abdulla, H., Tilbrook, S., Dean, R

[50] Research [edit] In September 2024, it was reported that a study found that liraglutide helped children aged 6 to 12 years of age reduce their body mass index by 7.4% in a 56-week trial

2023;37:e23258

The study one of seven trials planned found orforglipron is just as safe as other GLP-1 drugs, with the similar side effects like diarrhea and nausea

In 2024, the FDA approved resmetirom (Rezdiffra) for adults with noncirrhotic NASH with F2F3 fibrosis, marking the first approved pharmacotherapy specifically for this condition

A simple step-by-step plan Take creatine daily: use 5 grams of NutraBio creatine monohydrate per day to support phosphocreatine stores and high-intensity sets